Overview

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The investigators propose to use Belinostat in combination with AZT as consolidation therapy for the treatment of ATLL.
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami
Treatments:
Belinostat
Interferon alpha-2
Interferon-alfa-1b
Interferon-alpha
Interferons
Peginterferon alfa-2b
Zidovudine